The 2ndEdition of the International Cancer and Precision Oncology Conference (ICPOC2026) is delighted to welcome Dr. Zheng Weihui, Associate Researcher at Zhejiang Cancer Hospital, China.
🗣 Presentation
🔬 Session Highlights
- RET gene mutations and
Medullary Thyroid Carcinoma (MTC)
- Next-Generation Sequencing
(NGS) in precision oncology
- Association between RET
mutations and lymph node metastasis
- Clinical significance of p.M918T
and p.C618R/G mutations
- Predictive biomarkers for
lateral neck lymph node metastasis
- Improving surgical planning
and patient outcomes
- Precision medicine
approaches for thyroid cancer
👩⚕️ About
the Speaker
- Associate Researcher,
Zhejiang Cancer Hospital, China
- Clinician specializing in
thyroid and parathyroid surgery
- MD with postdoctoral
training
- Master's Supervisor
- Young Healthcare Talent of
Zhejiang Province
- Former Visiting Scholar at
Singapore's A*STAR
- Research focus on recurrent
laryngeal nerve preservation, parathyroid identification, and precision
thyroid cancer surgery
📅 November 23–25, 2026
📍 Singapore & Online
🌐 Website: https://cancer.miconferences.com/
📄 Abstract Submission: https://cancer.miconferences.com/abstract-submission
#ICPOC2026
#ThyroidCancer #PrecisionOncology #CancerResearch #RETMutation #NGS #Oncology
#SurgicalOncology
